Ruffer LLP Gilead Sciences, Inc. Transaction History

Ruffer LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 06, 2018	SELL	$71.28 - $78.92 $907,750 - $1.01 Million	-12,735 Closed	0 $0
Q2 2018 Jul 31, 2018	SELL	$64.88 - $75.68 $5,255 - $6,130	-81 Reduced 0.63%	12,735 $902,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $42,101 - $51,326	-578 Reduced 4.32%	12,816 $936,000
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $32,373 - $38,001	-455 Reduced 3.29%	13,394 $959,000
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $947,958 - $1.12 Million	-13,146 Reduced 48.7%	13,849 $1.12 Million
Q2 2017 Aug 11, 2017	BUY	N/A	26,995	26,995 $1.91 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ruffer LLP, based on Form 13F filings with the SEC.

Stay updated on Ruffer LLP with notifications on news.